Literature DB >> 313243

Presence of suppressor cells in spleens of mice bearing a weakly immunogenic syngeneic tumor.

S C Gautam, S D Deodhar.   

Abstract

Spleen cells of C57BL/6J mice bearing a poorly immunogenic syngeneic tumor T241 have been shown to suppress the mitogen-induced proliferative responses of normal spleen cells. However, no suppressive effect of these cells was observed on the generation of cytotoxic cells following immunization in vitro against H-2 histocompatibility antigens. The suppressor activity disappeared rapidly after the removal of the primary tumor. Spleen cells of tumor-bearing mice also suppressed the mitogen-induced stimulation of normal spleen cells of mice of different H-2 loci. Removal of phagocytic cells with carbonyl iron treatment had very little effect on the suppressor activity. Suppressor activity was enhanced following fractionation of cells through nylon wool columns. The suppressor population was found to resist anti-immunoglobulin serum and complement treatment, but treatment with anti-thymocyte serum and complement drastically reduced the suppressor activity. These results indicate that cells with suppressor activity have characteristics of T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313243

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Absence of generalized immunosuppression in C57BL/6J mice implanted with Lewis T241 fibrosarcoma or Lewis lung carcinoma.

Authors:  C E Jones; C T Lee; W Skinner; P Koyama; D Prescott
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

2.  Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762.

Authors:  J Bonaventure; V N Nigam; C A Brailovsky
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  Dept. of Microbiology, School of Medicine, East Carolina University, Greenville, NC.

Authors:  S C Gautam; S Gautam; S D Deodhar
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.